Saudi Pharmaceutical Industries and Medical Appliances Corp 2024 AR2
The report highlights SPIMACO's performance in 2024, focusing on operational efficiency, digital transformation, and strategic growth in the regional pharmaceutical industry. The company achieved a record production output of 2.3 billion units and successfully launched Endosa, the first GCC-manufactured biosimilar. Financially, SPIMACO recorded a net profit of SAR 31.84 million, representing a significant turnaround from the previous year's loss. On the sustainability front, the company reduced electricity consumption by over 20% across three major facilities, resulting in a 570,000 kg reduction in CO2 equivalent Scope 2 emissions, and earned an upgraded MSCI ESG rating of BBB.
Company: Saudi Pharmaceutical Industries and Medical Appliances Corp
Sector: Manufacturing
Country: Saudi Arabia
Year: 2024
Type: AR2
Pages: 92
Saudi Pharmaceutical Industries and Medical Appliances Corp
The report highlights SPIMACO's performance in 2024, focusing on operational efficiency, digital transformation, and strategic growth in the regional pharmaceutical industry. The company achieved a record production output of 2.3 billion units and successfully launched Endosa, the first GCC-manufactured biosimilar. Financially, SPIMACO recorded a net profit of SAR 31.84 million, representing a significant turnaround from the previous year's loss. On the sustainability front, the company reduced electricity consumption by over 20% across three major facilities, resulting in a 570,000 kg reduction in CO2 equivalent Scope 2 emissions, and earned an upgraded MSCI ESG rating of BBB.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Workplace Fatalities